HCV-associated cryoglobulinemic vasculitis with severe kidney involvement and B-cell lymphoma development. Monoclonal anti-CD-20 antibodies and antiviral therapy as options of prognosis improvement


Cite item

Full Text

Abstract

Clinical evolution of severe kidney damage, development of B-cell lymphoma, and advantages of antiviral therapy and rituximab are discussed

References

  1. Игнатова Т.М., Апросина З.Г., Серов В.В., Мухин Н.А.. Крель П.Е., Козловская Л.В. Внепеченочные проявления хронической НCV-инфекции. Росс. мед. ж. 2001; 32: 13-18.
  2. Козловская Л.В., Гордовская Н.Б., Малышко Е.Ю. Криоглобулинемическое поражение почек: особенности течения и лечения. Нефрол. и диализ. 2002. т.4. №1: 4-8.
  3. Милованова С.Ю., Игнатова Т.М., Козловская Л.В. Особенности течения хронического гепатита С с криоглобулинемией. Клин. гепатол. 2006; 2(1): 15-18
  4. Мухин Н А., Козловская Л.В., Малышко Е.Ю.; Криоглобулинемический нефрит, ассоциированный с хронической инфекцией вируса гепатита С. Тер. арх. 2000; 6: 1-5.
  5. Тэгай С.В., Лопаткина Т.Н., Косминкова Е.Н., Козловская Л.В. Поражение почек, ассоциированное с вирусами гепатитов В и С. Consilium Med. 2002; Т4. №7: 337-341
  6. Cacoub P, Delluc A, Saadoun D et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vaskulitis: where do we stand? Ann Rheum Dis 2008; 67(3): 283-287
  7. Cacoub P., Poynard T., Ghillani P et al. Extrahepatic manifestations of chronic hepatitis c. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999; 42: 2204-2212
  8. Cacoub P, Saadoun D, Limal N et al. PEGylated interferon alfa 2b and ribavirin treatment in patients with hepatititis C virus-related systemic vasculitis. Arthritis Rheum 2005; 52: 911-915
  9. Charles ED and Dustin LB. Hepatitis C virus induced cryoglobulinemia. Kidney Int. 2009; 76(8): 818-824.
  10. D'Amico G. Renal involvement in hepatitis С infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54:650
  11. Dammacco F., F.A. Tucci., G. Lauletta et al. Pegylated interferon-alfa, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long- term study. Blood. 2010; 116: 343-353
  12. Engels E.A., Chatterjee N., Cerhan JR. Hepatitis C virus infection and Non-Hodgkin lymphoma: result of the NCI-seer multi-center case control study. International of cancer. 2004; 111(1): 76-80
  13. Ferri C. Mixed cryoglobulinemia. Orphanet J of Rare. 2008; 3: 25.
  14. Geri G., Terrier B., Semoun O., Saadoun D et al. Surrogate markers of B-cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinemia vasculitis. Ann. Rheum. 2010; 69(12): 2177-80.
  15. Giannini C, Petrarca A., Monti M et al. Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood 2008; 111: 2943-2945
  16. Giordano TP., Henderson L., Langren O. Risk of Non-Hodgkin Lymphoma and Lymphoproliferative precursor diseases in US Veterans with hepatitis c virus. JAMA. 2007; 18: 2010-2017
  17. Jonson RJ, Gretch DR, Couser WG et al: Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int. 1994; 46: 1700-1704.
  18. Landau D-A, Saadoun D, Halfon P et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheumatism 2008; 58 (2): 604-611
  19. Nieters A., Kallinowski B., Brennan P et al. Hepatitis C and risk of Lymphoma: results of the European Multicenter Case-Control Study. EPILYMPH. Gastroenterol. 2006; 131: 1879-1886
  20. Petrarca A, Rigacci L, Caini P et al. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and sever liver disease. Blood 2010; 116(3): 335-342
  21. Saadoun D., Landau DA., Calabrese LH., Cacoub P. Hepatitis c-associated mixed cryoglobulinemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology. 2007; 46:1234-1242
  22. Saadoun D, Reache-Rigon M, Thibault V et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis. A long-term follow up study. Arthritis Rheumatism 2006; 54(11): 3696-3706
  23. Saadoun D., M.R. Rigon., D. Sene. et al. Rituximab plus Peg-interferon-alfa/ribavirin compared with Peginterferon-alfa/ ribavirin in hepatitis C - related mixed cryoglobulinemia. Blood. 2010;116:326-334
  24. Trejo O., Ramos-Casals M., Garcia-Carrasco M. Cryoglobulinemia: study of etiologic factors and clinical and immunologic in 443 patients from a simple center. Medicine. 2001. 8. 252-262
  25. Vallisa D., Bernuzzi P., Arcaini L et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J. Clin. Oncol. 2005; 23: 468-473.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies